Eleanor Bergren
Biographic Data
| ID | 9072066 |
|---|---|
| NAME | Eleanor Bergren |
| GIVEN NAMES | Eleanor |
| FAMILY NAME | Bergren |
| SIGNATURE | BERGREN E |
| AFFILIATIONS | London School of Hygiene & Tropical Medicine |
| ORCID | 0000-0001-8270-5677 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
What, how and who
While safe and efficacious COVID-19 vaccines have achieved high coverage in high-income settings, roll-out remains slow in sub-Saharan Africa. By April 2022, Nigeria, a country of over 200 million people, had only distributed 34 million doses. To ensure the optimal use of health resources, cost-effectiveness analyses can inform key policy questions in the health technology assessment process. We carried out several cost-effectiveness analyses exp…
No prominent works on this page.
What, how and who
While safe and efficacious COVID-19 vaccines have achieved high coverage in high-income settings, roll-out remains slow in sub-Saharan Africa. By April 2022, Nigeria, a country of over 200 million people, had only distributed 34 million doses. To ensure the optimal use of health resources, cost-effectiveness analyses can inform key policy questions in the health technology assessment process. We carried out several cost-effectiveness analyses exp…
Activity-based costing (1 work) · Business (1 work) · Cost effectiveness (1 work) · COVID-19 epidemiological studies (1 work) · Economic growth (1 work) · Economics (1 work) · Environmental health (1 work) · Health care (1 work) · Immunology (1 work) · Marketing (1 work)